Early treatment helps baby recover from rare disorder’s complications
Case report describes recovery from aHUS and severe pulmonary hypertension
Written by |
A recent case report described a baby whose rare genetic disorder manifested as atypical hemolytic uremic syndrome (aHUS) and pulmonary arterial hypertension, a condition affecting the blood vessels in the lungs.
After diagnosis and treatment, the girl’s symptoms improved rapidly, and she continued to grow normally for her age, researchers reported.
The study, “A case report of cobalamin C deficiency presenting with atypical hemolytic uremic syndrome and life-threatening pulmonary arterial hypertension in a Chinese infant,” was published in BMC Pediatrics.
Rare genetic disorder can cause serious blood vessel complications
aHUS is a condition in which blood clots form in small blood vessels, potentially damaging the kidneys and other organs. In some cases, this can result from an underlying genetic disorder called cobalamin C deficiency, which prevents the body from properly processing vitamin B12.
Researchers in China described a 4-month-old girl who was hospitalized with persistent jaundice (yellowing of the skin and whites of the eyes) and blood in her urine, which had appeared the day before. She had no family history of inherited metabolic diseases.
Blood tests showed a sharp drop in platelets, which help blood clot, and signs of red blood cell destruction, consistent with damage to small blood vessels. After ruling out other possible causes, doctors reached a diagnosis of aHUS.
Three days after admission, the baby developed difficulty breathing and cyanosis (a bluish discoloration of the skin caused by low oxygen levels). An echocardiogram, an ultrasound examination of the heart, revealed severe pulmonary arterial hypertension (PAH), in which blood pressure is abnormally high in the arteries carrying blood from the heart to the lungs. This makes the heart work harder to pump blood through the lungs.
aHUS and PAH have been reported together in people with cobalamin C deficiency. Genetic testing identified two disease-causing variants in the MMACHC gene, confirming that the baby had the disorder.
Early treatment leads to rapid improvement in baby
The baby’s aHUS and PAH were linked to the same underlying genetic disorder, cobalamin C deficiency. Doctors promptly began treatment following established guidelines, using medications to support her heart and lungs, along with vitamin supplements and other therapies to manage her metabolic disorder. She improved rapidly and remained clinically stable during nearly four years of follow-up, researchers reported.
“Clinical improvement was rapid: pulmonary artery pressure returned to normal within 1 week, and respiratory symptoms resolved completely. Hematologic [blood] and renal parameters normalized within 2 weeks,” they wrote.
According to the researchers, only about a dozen cases of cobalamin C deficiency involving both aHUS and PAH have been documented. The researchers said the case highlights the importance of considering this rare genetic disorder when the two conditions occur together.
“Early diagnosis and combined multidisciplinary intervention can achieve excellent long-term clinical and neurodevelopmental outcomes. … Â Clinicians should maintain a high index of suspicion for [cobalamin C] deficiency in all infants with unexplained aHUS or PAH to ensure timely and life-saving intervention.”
Leave a comment
Fill in the required fields to post. Your email address will not be published.